AstraZeneca's IP Suit Sent To W.Va. On TC Heartland Grounds
A Delaware federal judge on Friday transferred AstraZeneca AB's suit accusing Mylan Pharmaceuticals Inc. of infringing patents for its asthma treatment Symbicort to West Virginia court, invoking the U.S. Supreme Court's...To view the full article, register now.
Already a subscriber? Click here to view full article